OBJECTIVE: The purpose of this study was to evaluate clinical aspects of recanalization and to assess variables associated with early recanalization. METHODS: In all, 27 consecutive patients treated with intravenous thrombolysis were examined with the National Institutes of Health Stroke Scale (NIHSS) and transcranial Doppler ultrasound at presentation and at 2 and 24 hours after treatment. RESULTS: Recanalization less than 24 hours after treatment was found in 70% of patients. Patients who recanalized had lower NIHSS score on presentation (P = .01) and significant improvement in NIHSS score at 0 to 2 hours (P = .042) and 0 to 24 hours (P = .002) compared with those who did not recanalize. Atrial fibrillation (P = .04), higher serum glucose values on presentation (P = .05), and more traditional risk factors (P = .05) were associated with no recanalization. CONCLUSIONS: Recanalization is associated with clinical improvement. High NIHSS score, atrial fibrillation, high serum glucose, and higher number of risk factors indicate a reduced probability for recanalization.
OBJECTIVE: The purpose of this study was to evaluate clinical aspects of recanalization and to assess variables associated with early recanalization. METHODS: In all, 27 consecutive patients treated with intravenous thrombolysis were examined with the National Institutes of Health Stroke Scale (NIHSS) and transcranial Doppler ultrasound at presentation and at 2 and 24 hours after treatment. RESULTS: Recanalization less than 24 hours after treatment was found in 70% of patients. Patients who recanalized had lower NIHSS score on presentation (P = .01) and significant improvement in NIHSS score at 0 to 2 hours (P = .042) and 0 to 24 hours (P = .002) compared with those who did not recanalize. Atrial fibrillation (P = .04), higher serum glucose values on presentation (P = .05), and more traditional risk factors (P = .05) were associated with no recanalization. CONCLUSIONS: Recanalization is associated with clinical improvement. High NIHSS score, atrial fibrillation, high serum glucose, and higher number of risk factors indicate a reduced probability for recanalization.
Authors: A D Horsch; J W Dankbaar; J M Niesten; T van Seeters; I C van der Schaaf; Y van der Graaf; W P Th M Mali; B K Velthuis Journal: AJNR Am J Neuroradiol Date: 2015-04-23 Impact factor: 3.825
Authors: G Gascou; K Lobotesis; P Machi; I Maldonado; J F Vendrell; C Riquelme; O Eker; G Mercier; I Mourand; C Arquizan; A Bonafé; V Costalat Journal: AJNR Am J Neuroradiol Date: 2013-10-24 Impact factor: 3.825
Authors: Hans T H Tu; Bruce C V Campbell; Soren Christensen; Patricia M Desmond; Deidre A De Silva; Mark W Parsons; Leonid Churilov; Maarten G Lansberg; Michael Mlynash; Jean-Marc Olivot; Matus Straka; Roland Bammer; Gregory W Albers; Geoffrey A Donnan; Stephen M Davis Journal: Int J Stroke Date: 2013-03-12 Impact factor: 5.266
Authors: Amrou Sarraj; James Grotta; Gregory W Albers; Ameer E Hassan; Spiros Blackburn; Arthur Day; Clark Sitton; Michael Abraham; Chunyan Cai; Mark Dannenbaum; Deep Pujara; William Hicks; Ronald Budzik; Nirav Vora; Ashish Arora; Bader Alenzi; Wondwossen G Tekle; Haris Kamal; Osman Mir; Andrew D Barreto; Maarten Lansberg; Rishi Gupta; Sheryl Martin-Schild; Sean Savitz; Georgios Tsivgoulis Journal: Neurology Date: 2021-04-19 Impact factor: 11.800
Authors: Feras Akbik; Ali Alawieh; Alejandro M Spiotta; Jonathan A Grossberg; C Michael Cawley; Brian M Howard; Frank C Tong; Fadi Nahab; Hassan Saad; Laurie Dimisko; Christian Mustroph; Owen B Samuels; Gustavo Pradilla; Ilko Maier; Nitin Goyal; Robert M Starke; Ansaar Rai; Kyle M Fargen; Marios N Psychogios; Pascal Jabbour; Reade De Leacy; James Giles; Travis M Dumont; Peter Kan; Adam S Arthur; Roberto Javier Crosa; Benjamin Gory Journal: J Neurointerv Surg Date: 2020-12-14 Impact factor: 8.572